Dr. Sudha Sinha

MBBS, MD (USA), DM (USA) American Board Certified

Department- Oncology

Dr. Sudha Sinha

Discount Upto 35%

MBBS, MD (USA), DM (USA) American Board Certified

Dr. Sudha Sinha is a Clinical Director & HOD, Medical Oncology Senior Consultant Medical Oncology & Hematology in Care Hospital and has an experience of 24 years. She completed MBBS from Gandhi Medical College, University of Health Sciences, Hyderabad in 1996, Intern in Internal Medicine at St. Barnabas Medical Center Livingston, NJ. USA from 1998-1999, Resident in Internal Medicine at Barnabas Medical Center Livingston, NJ. USA from 1999- 2001,Fellowship in Hematology and Oncology from Caritas St. Elizabeth’s Medical Center Tufts University School of Medicine Boston, MA. USA from 2002 -2005, Chief Fellow, Division of Hematology/Oncology at Caritas St. Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, MA. USA from 2004-2005. ...Read more

CARE Super Specialty Hospital – Hi Tech City

Old Mumbai Hwy, Near Cyberabad Police Commissionerate, Jayabheri Pine Valley, HITEC City, Hyderabad, Telangana 500032

OPD fee: ₹ 600

Timing

11 00 AM to 05 00 PM
11 00 AM to 05 00 PM

Practicing since

24 Years

Designation

Clinical Director & HOD, Medical Oncology Senior Consultant Medical Oncology & Hematology

Department

Oncology

Specialization

Hematooncology, Oncology

Acheivement /honors

Chirivella S, Rajappa S, Sinha S, Eden T, Barr RD. Indian J Pediatr. 2009 Dec;76(12):1231-Health-Related Quality of life among Children with cancer In Hyderabad, India.

Expression And Purification of Erythrocyte Macrophage Protein (EMP).

Development of Anti-EMP Antibodies.

26th Annual Meeting of American Society of Aphereis (ASFA) 2005-Plenary Session: Safety And Efficacy of Peripheral Blood Progenitor Cell Mobilization And Collection in Patients With Advanced Coronary Heart Disease.

46th Annual Meeting of American Society of Hematology (ASH) 2005 – Practice Forum: The Business of Practice: The Evolving State Of Hematology Practice – Progress And Challenges In 2004 Advocacy Efforts.